MON-LB329: Taurolidine-Citrate CVC-Lock Solution Reduces CRBSI Rate in Patients with Chronic Intestinal Failure in HPN

MLA

C. Ivaldi, et al. “MON-LB329: Taurolidine-Citrate CVC-Lock Solution Reduces CRBSI Rate in Patients with Chronic Intestinal Failure in HPN.” Clinical Nutrition, vol. 36, Sept. 2017, p. S301. EBSCOhost, https://doi.org/10.1016/s0261-5614(17)31097-x.

APA

C. Ivaldi, F.D. Merlo, U. Aimasso, & A. De Francesco. (2017). MON-LB329: Taurolidine-Citrate CVC-Lock Solution Reduces CRBSI Rate in Patients with Chronic Intestinal Failure in HPN. Clinical Nutrition, 36, S301. https://doi.org/10.1016/s0261-5614(17)31097-x

Chicago

C. Ivaldi, F.D. Merlo, U. Aimasso, and A. De Francesco. 2017. “MON-LB329: Taurolidine-Citrate CVC-Lock Solution Reduces CRBSI Rate in Patients with Chronic Intestinal Failure in HPN.” Clinical Nutrition 36 (September): S301. doi:10.1016/s0261-5614(17)31097-x.